Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1980 2
1984 2
1985 1
1988 1
1992 3
1993 1
1995 2
1997 1
1998 1
1999 2
2000 1
2002 7
2003 2
2004 6
2005 5
2006 2
2007 7
2008 4
2009 8
2010 9
2011 8
2012 13
2013 12
2014 9
2015 6
2016 7
2017 7
2018 6
2019 10
2020 7
2021 5
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 23683667

152 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study.
Morgia G, Cimino S, Favilla V, Russo GI, Squadrito F, Mucciardi G, Masieri L, Minutoli L, Grosso G, Castelli T. Morgia G, et al. Int Braz J Urol. 2013 Mar-Apr;39(2):214-21. doi: 10.1590/S1677-5538.IBJU.2013.02.10. Int Braz J Urol. 2013. PMID: 23683667 Free article. Clinical Trial.
Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
Morgia G, Mucciardi G, Galì A, Madonia M, Marchese F, Di Benedetto A, Romano G, Bonvissuto G, Castelli T, Macchione L, Magno C. Morgia G, et al. Urol Int. 2010;84(4):400-6. doi: 10.1159/000302716. Epub 2010 Mar 24. Urol Int. 2010. PMID: 20332612 Clinical Trial.
Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
Bertaccini A, Giampaoli M, Cividini R, Gattoni GL, Sanseverino R, Realfonso T, Napodano G, Fandella A, Guidoni E, Prezioso D, Galasso R, Cicalese C, Scattoni V, Armenio A, Conti G, Corinti M, Spasciani R, Liguori G, Lampropoulou N, Martorana G. Bertaccini A, et al. Arch Ital Urol Androl. 2012 Sep;84(3):117-22. Arch Ital Urol Androl. 2012. PMID: 23210402
Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial).
Morgia G, Russo GI, Voce S, Palmieri F, Gentile M, Giannantoni A, Blefari F, Carini M, Minervini A, Ginepri A, Salvia G, Vespasiani G, Santelli G, Cimino S, Allegro R, Collura Z, Fragalà E, Arnone S, Pareo RM. Morgia G, et al. Prostate. 2014 Nov;74(15):1471-80. doi: 10.1002/pros.22866. Epub 2014 Aug 23. Prostate. 2014. PMID: 25154739 Clinical Trial.
Multicentre study on the efficacy and tolerability of an extract of Serenoa repens in patients with chronic benign prostate conditions associated with inflammation.
Giulianelli R, Pecoraro S, Sepe G, Leonardi R, Gentile BC, Albanesi L, Brunori S, Mavilla L, Pisanti F, Giannella R, Morello P, Tuzzolo D, Coscione M, Galasso F, D'Angelo T, Ferravante P, Morelli E, Miragliuolo A; Cooperative Ur.O.P Group. Giulianelli R, et al. Arch Ital Urol Androl. 2012 Jun;84(2):94-8. Arch Ital Urol Androl. 2012. PMID: 22908779 Clinical Trial.
152 results